Literature DB >> 16344467

Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.

Jason G S Ho1, Antonio Greco, Maja Rupnik, Kenneth K-S Ng.   

Abstract

Clostridium difficile is a major nosocomial pathogen that produces two large protein toxins [toxin A (TcdA) and toxin B (TcdB)] capable of disrupting intestinal epithelial cells. Both belong to the family of large clostridial cytotoxins, which are characterized by the presence of a repetitive C-terminal repetitive domain (CRD). In TcdA, the CRD is composed of 39 repeats that are responsible for binding to cell surface carbohydrates. To understand the molecular structural basis of cell binding by the toxins from C. difficile, we have determined a 1.85-A resolution crystal structure of a 127-aa fragment from the C terminus of the toxin A CRD. This structure reveals a beta-solenoid fold containing five repeats, with each repeat consisting of a beta-hairpin followed by a loop of 7-10 residues in short repeats (SRs) or 18 residues in long repeats (LRs). Adjacent pairs of beta-hairpins are related to each other by either 90 degree or 120 degree screw-axis rotational relationships, depending on the nature of the amino acids at key positions in adjacent beta-hairpins. Models of the complete CRDs of toxins A and B suggest that each CRD contains straight stretches of beta-solenoid composed of three to five SRs that are punctuated by kinks introduced by the presence of a single LR. These structural features provide a framework for understanding how large clostridial cytotoxins bind to cell surfaces and suggest approaches for developing novel treatments for C. difficile-associated diseases by blocking the binding of toxins to cell surfaces.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344467      PMCID: PMC1317924          DOI: 10.1073/pnas.0506391102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Automated structure solution, density modification and model building.

Authors:  Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

2.  Comparative sequence analysis of the Clostridium difficile toxins A and B.

Authors:  C von Eichel-Streiber; R Laufenberg-Feldmann; S Sartingen; J Schulze; M Sauerborn
Journal:  Mol Gen Genet       Date:  1992-05

3.  Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases.

Authors:  C von Eichel-Streiber; M Sauerborn; H K Kuramitsu
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

4.  A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon.

Authors:  C Pothoulakis; U Galili; I Castagliuolo; C P Kelly; S Nikulasson; P K Dudeja; T A Brasitus; J T LaMont
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

5.  A novel solenoid fold in the cell wall anchoring domain of the pneumococcal virulence factor LytA.

Authors:  C Fernández-Tornero; R López; E García; G Giménez-Gallego; A Romero
Journal:  Nat Struct Biol       Date:  2001-12

6.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile.

Authors:  M Rupnik; V Braun; F Soehn; M Janc; M Hofstetter; R Laufenberg-Feldmann; C von Eichel-Streiber
Journal:  FEMS Microbiol Lett       Date:  1997-03-15       Impact factor: 2.742

8.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

9.  Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding.

Authors:  R D Rolfe; W Song
Journal:  J Med Microbiol       Date:  1995-01       Impact factor: 2.472

10.  The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins.

Authors:  I Just; M Wilm; J Selzer; G Rex; C von Eichel-Streiber; M Mann; K Aktories
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

View more
  60 in total

1.  Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.

Authors:  Rory N Pruitt; Nicole M Chumbler; Stacey A Rutherford; Melissa A Farrow; David B Friedman; Ben Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

2.  Structural organization of the functional domains of Clostridium difficile toxins A and B.

Authors:  Rory N Pruitt; Melissa G Chambers; Kenneth K-S Ng; Melanie D Ohi; D Borden Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

3.  Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface.

Authors:  Heather K Kroh; Ramyavardhanee Chandrasekaran; Kim Rosenthal; Rob Woods; Xiaofang Jin; Melanie D Ohi; Andrew C Nyborg; G Jonah Rainey; Paul Warrener; Benjamin W Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2017-07-13       Impact factor: 5.157

4.  Chemical Genomics, Structure Elucidation, and in Vivo Studies of the Marine-Derived Anticlostridial Ecteinamycin.

Authors:  Thomas P Wyche; René F Ramos Alvarenga; Jeff S Piotrowski; Megan N Duster; Simone R Warrack; Gabriel Cornilescu; Travis J De Wolfe; Yanpeng Hou; Doug R Braun; Gregory A Ellis; Scott W Simpkins; Justin Nelson; Chad L Myers; James Steele; Hirotada Mori; Nasia Safdar; John L Markley; Scott R Rajski; Tim S Bugni
Journal:  ACS Chem Biol       Date:  2017-07-26       Impact factor: 5.100

5.  Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.

Authors:  Shan Li; Lianfa Shi; Zhiyong Yang; Yongrong Zhang; Gregorio Perez-Cordon; Tuxiong Huang; Jeremy Ramsey; Numan Oezguen; Tor C Savidge; Hanping Feng
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

6.  Nonantimicrobial drug targets for Clostridium difficile infections.

Authors:  Charles Darkoh; Magdalena Deaton; Herbert L DuPont
Journal:  Future Microbiol       Date:  2017-07-31       Impact factor: 3.165

7.  Crystal structure of Clostridium difficile toxin A.

Authors:  Nicole M Chumbler; Stacey A Rutherford; Zhifen Zhang; Melissa A Farrow; John P Lisher; Erik Farquhar; David P Giedroc; Benjamin W Spiller; Roman A Melnyk; D Borden Lacy
Journal:  Nat Microbiol       Date:  2016-01-11       Impact factor: 17.745

8.  Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis.

Authors:  Panagiotis Papatheodorou; Constantinos Zamboglou; Selda Genisyuerek; Gregor Guttenberg; Klaus Aktories
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

Review 9.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

10.  Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

Authors:  Satya Prakash; Aleksandra Malgorzata Urbanska
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.